-
-
-
2024 Global CAR-T Sales Performance
CAR-T
Discover the sales performance of CAR-T therapies in 2024, including Kymriah, Yescarta, Breyanzi, and more. Explore trends, growth, and challenges in the CAR-T cell therapy market across the US and beyond.
-
-
Novartis 2024 Q4 Financial Report
Financial statements
Novartis' 2024 financial report highlights strong growth with key products like Entresto, Cosentyx, and Pluvicto. The company saw a 12% revenue increase, with China market sales up 21%. Strong prospects include new treatments and strategic acquisitions.
-
Top 10 Immunology Drugs to Watch in 2024
AbbVie
Explore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
-
November Biopharmaceutical Company Layoff Summary
Layoff
November 2024 saw significant layoffs in the biopharma industry, with 20 companies announcing cuts due to economic pressures, failed projects, and restructuring. Key layoffs include major firms like 23andMe, Novartis, and Bristol Myers Squibb.
-
-
-
穆棱市|
都安|
施甸县|
澄江县|
蓬莱市|
娄烦县|
祥云县|
巴彦县|
龙里县|
长海县|
阳山县|
交城县|
菏泽市|
河北省|
沂水县|
文山县|
万全县|
台前县|
黔东|
六安市|
清涧县|
富裕县|
平江县|
昌都县|
墨江|
长治市|
泰兴市|
利津县|
陆河县|
纳雍县|
广河县|
新宾|
巨鹿县|
安泽县|
秦皇岛市|
沛县|
上虞市|
东明县|
青岛市|
宜黄县|
东阳市|